The finding of numerous studies have established the link between stromal-expressed FAP, particularly FAP+ CAFs, and pancreatic cancer, thereby indicating the potential ultility of FAP as a target in PAAD treatment (Figure 4). This evidence concerns the gene FAP and familial pancreatic carcinoma.